Project Grant R34AA031870
Award Date
9/20/24
Completion Date
8/31/27
Dollars Obligated
$390K
Funding Federal Agency
National Institute on Drug Abuse
Awarding Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project titled "Implementing a Digital Therapeutic to Address Substance Use Disorders Among People Who Are Incarcerated." The $355,414 award to Yale University will fund a 5-year study to assess the feasibility, acceptability, and preliminary efficacy of implementing an evidence-based digital therapeutic, Computer-Based...
The National Institute on Drug Abuse (NIDA) awarded a $445,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Children's Hospital Corporation (Boston Children's Hospital) to develop and pilot test a novel telehealth and mobile health intervention called MOMENT-V for treating cannabis use disorder in young adults. The intervention combines remote motivational enhancement therapy with ecological momentary interventions delivered via mobile app. The pilot...
The National Institute on Drug Abuse (NIDA) awarded a $857,121 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Meaningful Measurement, Inc., a woman-owned small business. The grant aims to develop and test a prototype mobile health application called R-ASSIST to support individuals with co-occurring opioid use and mental health disorders released from jail. Key features of R-ASSIST will include daily symptom and medication monitoring, a self-help curriculum, a...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding the development and pilot evaluation of a digital therapeutic called AMP-C. The goal of AMP-C is to address the comorbidity of cannabis use disorder (CUD) and major depressive disorder (MDD) by targeting reward dysfunction, a key shared mechanism underlying these co-occurring conditions. The $197,640 award to the General Hospital...
This $591,032 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development of the "COGITO" digital therapeutics platform. COGITO is intended to provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics to prevent, treat, or manage a wide range of health conditions with behavioral components. The funding will be used to finalize key...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,415,940 to the University of Massachusetts Medical School (UMass Medical) to conduct a prospective, observational study on using digital biomarkers from wearable sensors to understand craving patterns during medications for opioid use disorder (MOUD) treatment. The key goals are to: 1) curate a high-quality dataset of craving...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, provides $2,851,692 in funding to the University of Illinois to test the effectiveness and implementation of a meditation mobile app in addressing substance use, sexual health, and emotion regulation among youth involved in the legal system. The key activities funded under this award include: 1) Conducting a hybrid Type 2 effectiveness-implementation...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop and evaluate a customized version of the "MyTrials" remote biomarker capture system for use in decentralized clinical trials (DCTs) for substance use disorders (SUDs). The key products and services to be delivered include: 1) Refinement of the existing MyTrials prototype to support the...